IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

The company had initially claimed 20 billion yen (RM581.9mil) that Daiichi was ordered to pay as damages to NTK in November 2023.

After a report by an expert, NTK now claims compensation of between 4.24 billion rupees and 109.3 billion rupees.

IHH Healthcare, Asia’s largest healthcare group, had halted its open offer to buy an additional 26% stake in Fortis after Daiichi filed a contempt plea against Fortis founders, according to media reports.

Both Daiichi and Fortis did not immediately respond to a Reuters request for comment. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit ends mostly higher against major currencies, but weakens vs US dollar
MBSB Bank provides RM29.6mil financing to Bisajuta for Sabah infrastructure projects
Reservoir Link secures PPA for 200MWac solar facility in Sarawak
MASkargo, IAG Cargo and Qatar Airways Cargo complete first customer shipment trial
Citi appoints Yik Ping Chong as Malaysia commercial banking head
Binastra records 93.4% revenue growth in 1H27, declares 4.0 sen dividend
FBM KLCI falls amid broad selling, ringgit sinks to one-month low
Malaysia strengthens aerospace position as local players move up value chain
Moody’s: 14-17GW additional power capacity to require up to RM95bil investment over 10 years
Malaysia treasurers bullish on AI, digital currencies despite integration barriers

Others Also Read